上市后业绩持续下滑，部分募投项目延期 元道通信（301139.SZ）涉财务造假正在被证监会立案调查，并存在强制退市风险。 7月11日，元道通信发布公告称，因公司涉嫌年报等信息披露文件财务数据存在虚假记载等违法行为， 证监会决定对其立案。若后续行政处罚认定的事实触及重大违法强制退市情形，该公司股票将被强制退 市。 上市以来，元道通信业绩持续下滑，2024年审计报告被出具"保留意见"，此外该公司还存在部分募投项 目延期、股价长期破发等情况。 在业内人士看来，该公司涉嫌信息披露违法，可能存在退市风险，投资者应当充分关注投资风险，谨慎 投资。 2025年一季度，该公司业绩仍未实现正增长，一季度营业收入3.07亿元，同比下降26.78%；归母净利润 为1063.6万元，同比下降47.67%。 对于2024年业绩下滑原因，元道通信此前披露，下降主要由于公司主动优化业务结构，减少低效益项 目；运营商投资方向调整导致传统通信工程建设需求减少；新兴业务尚处于投入期，尚未完全贡献利 润；财务费用因新增融资渠道增加；政府补助减少等。 在业绩持续下滑的同时，因公司被识别出内部控制存在缺陷、应收款项坏账准备计提可能存在问题，元 道通信 ...

本公司及监事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 一、监事会会议召开情况 青岛海泰科模塑科技股份有限公司（以下简称"公司"）第二届监事会第二十五次 会议于 2025 年 7 月 11 日在公司会议室召开，会议采取现场和通讯结合的方式召开。 本次会议通知于 2025 年 7 月 5 日以专人送达、电子邮件、电话、微信等方式发出。 会议应到监事 3 人，实到 3 人，会议由监事会主席任勇先生主持。本次监事会的召集、 召开符合《公司法》、《公司章程》及相关法规的规定。 证券代码：301022 证券简称：海泰科 公告编号：2025-086 债券代码：123200 债券简称：海泰转债 青岛海泰科模塑科技股份有限公司 表决结果：同意 3 票，反对 0 票，弃权 0 票。本议案获得表决通过。 案》 经审议，监事会认为：公司本次延期归还闲置募集资金并继续用于暂时补充流动 资金，是基于公司募集资金投资项目的进度做出的合理资金安排，有利于提高募集资 金使用效率，不存在变相改变募集资金用途的情况，不影响募集资金投资项目的正常 进行，符合《上市公司募集资金监管规则》 二、监事会会议审议 ...

2025年7月4日，安井食品集团股份有限公司（02648.HK，以下简称"安井食品"）正式登陆港交所，成为中国速冻食品行业首家"A+H"上市公司。然而，该公 司以破发亮相的港股首秀，也引发市场的疑问：这家速冻巨头怎么了？ 安井食品此次港股上市共计发售3999.47万股H股，发行价为每股60港元，募集资金24亿港元，募资用途分别为扩大销售及经销网络、提升采购能力、优化供 应链及搭建供应链系统、业务营运数字化、产品开发及技术创新等。 从配售情况来看，安井食品公开发售阶段获得44.2倍超额认购，国际配售获得5.85倍认购，投资者整体参与度中规中矩，但不及市场预期。而随着安井食品 将其最终发行价较原计划上限下调9.1%，也为其上市首日遇冷埋下伏笔。 对此，安井食品向GPLP犀牛财经回复称，该公司股票受到经济环境、市场情绪、资金属性等多方面因素综合影响，短期内出现一定波动属于正常现象；新 股发行定价的适度调整，是国际资本市场常见的市场化操作，其核心目的是促进新股在上市后拥有更健康以及可持续的流动性表现，有利于公司股价的长期 稳定。 "发行定价的适度调整不会影响公司的内在价值和发展前景，公司赴港上市将带来长期战略价值，也 ...

Core Viewpoint - Junya Technology (603386.SH) faces significant challenges, including declining performance, delayed investment projects, and a lack of competitiveness in the high-layer PCB market, which has led to a three-year consecutive decline in revenue and profit [2][3][10] Financial Performance - The company reported revenues of 2.573 billion yuan in 2022, 2.427 billion yuan in 2023, and projected 2.347 billion yuan in 2024, with net profits of 163 million yuan, 69 million yuan, and a loss of 154 million yuan respectively, indicating a downward trend [2] - The gross margin plummeted from 18.63% in 2022 to 9.30% in 2024, a decrease of 9.33 percentage points [3][6] Market Position and Product Strategy - Junya Technology's core product, PCB, accounted for 88.64% of revenue in 2024, but revenue from PCB declined from 2.34 billion yuan in 2022 to 2.08 billion yuan in 2024 [3][6] - The company has a low presence in high-layer PCBs (8 layers and above), with only 9% market share, while competitors have successfully targeted high-growth areas such as AI servers and high-speed communication [4][5] Customer Dependency and Sales Strategy - The company's largest customer, Flex, saw sales drop from 166 million yuan in 2023 to 46.81 million yuan in 2024, forcing Junya to adopt a low-margin domestic sales strategy to maintain production [3][4] Acquisition and Investment Issues - Junya Technology's aggressive acquisitions in 2019 resulted in significant goodwill, but the acquired companies have underperformed, leading to impairment losses [7] - The company initiated a fundraising project in 2021 for a high-precision PCB project, but actual funds raised were only 184 million yuan, with project completion delayed to December 2025 and only 53.63% of the investment made by the end of 2024 [8][9][10]

Core Viewpoint - The company has faced multiple delays in its fundraising project due to various market and economic factors, leading to a cautious approach in capital investment and project implementation [1][2][3] Group 1: Fundraising Project Delays - The company raised a net amount of 184 million RMB from a non-public stock issuance in 2020, intended for an 800,000 square meter smart interconnected high-precision circuit board project, which has been delayed multiple times, now expected to complete by December 2025 [1] - The project has seen a total investment of 23 million RMB in 2024, with 65 million RMB of the raised funds still unreturned as of May 2024 [1] - The company’s monetary funds and long-term borrowings totaled 518 million RMB by the end of 2024 [1] Group 2: Market Environment and Business Development - The consumer electronics market saw a decline of 2.37% in 2023, with a projected compound annual growth rate (CAGR) of only 2.25% from 2023 to 2028, significantly lower than the global electronics CAGR of 5.7% [2] - The company’s products are primarily used in consumer electronics and renewable energy sectors, facing intense competition and longer product certification cycles [2][3] - The company has been cautious in capital investments since Q4 2021, slowing down project implementation to mitigate adverse impacts on performance due to market conditions [3] Group 3: Financial Performance - The company reported a revenue of 234.72 million RMB in 2024, down 3.30% year-on-year, with a net loss of 15.44 million RMB, a significant decline of 325.20% compared to the previous year [5] - The company’s performance has been under pressure due to macroeconomic factors, leading to a cautious approach in project funding and execution [5][6] Group 4: Fund Utilization and Compliance - The company has utilized part of the raised funds for temporary working capital, with a total of 160 million RMB returned to the special account by the end of 2023 [10][12] - The company has ensured that the use of funds complies with regulations, with no evidence of misappropriation or violation of fund usage rules [14]

核查意见 华泰联合证券有限责任公司 关于东鹏饮料（集团）股份有限公司 部分募投项目延期的核查意见 根据《证券发行上市保荐业务管理办法》、 截至期 | 末 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | 承诺投资项 | 募集资金专户 | | 项目投资总 | | 已累计投入 | | | 募 | 截至期末 | | | | | | | | 序号 | | | 账号 | | | | 募 | | 集资金 | | | | | | | | | | 目 | 开户行 | | 额 | 集资金总额 | | 投入进 | | 度 | | | | | | | | | | | | | | | | 余额 | | | | 招商银行股份 | | | | | | | | 华南生产基 | | | | | | | | | 地建设项目 | | | | | | | | | | 中央商务支行 | | | | | | | | 重庆西彭生 | 招商银行股份 | | | | | | | 项目 | | 中央商务支行 | | | | | | | | 南宁生产基 | 中国建设银行 ...

Group 1 - The company announced a change in the use of part of the raised funds and a delay in investment projects, specifically reducing the investment amount for the "Konjac Deep Processing Intelligent Manufacturing Production Line Expansion and Renovation Project" from 101.05 million yuan to 91.36 million yuan, reallocating 26 million yuan for the construction of the Hydrophilic Colloid Industrial Park Renovation and Digital Transformation Project (Phase I) [2] - The "Konjac Deep Processing Intelligent Manufacturing Production Line Expansion and Renovation Project" was initially planned in 2022 based on market conditions and company circumstances, and the company has adhered to regulations regarding the use of raised funds while ensuring the project's smooth implementation [2] - As of May 31, 2025, the basic construction of the project, including civil works and equipment, has been completed [2] Group 2 - The company plans to extend the "Konjac Deep Processing Intelligent Manufacturing Production Line Expansion and Renovation Project" deadline to December 2025, utilizing working capital during the extension period to purchase raw materials needed for production [3] - The total planned investment for the "Hydrophilic Colloid Industrial Park Renovation and Digital Transformation Project (Phase I)" is 56.04 million yuan, with 26 million yuan sourced from the original raised funds, while the remaining amount will be financed through the company's own or self-raised funds [3] - The completion of the project is expected to enhance the company's production capacity for hydrophilic colloids, meet market demand, and improve the company's market competitiveness and profitability, thereby expanding future development opportunities [3]

壹石通于2022年7月26日获得中国证券监督管理委员会的批复，同意公司向特定对象发行人民币普通股股票（A股）17,610,850股，募集资金 总额为人民币950,985,900元，扣除发行费用后实际募集资金净额为人民币929,804,701.21元。募集资金主要用于"年产15,000吨电子功能粉体材 料建设项目"、"年产20,000吨锂电池涂覆用勃姆石建设项目"、"技术研发中心建设项目"及补充流动资金。 "年产15,000吨电子功能粉体材料建设项目"中的子项目重庆基地"年产9,800吨导热用球形氧化铝项目"进行了工艺优化升级，并涉及相关行政 审批手续的调整。截至目前，该子项目已完成生产线主体建设，但工艺优化升级所需的部分辅助设备仍在推进落地过程中。同时，相关行政 审批手续的办理周期较长，导致项目实施进度有所延缓。基于上述原因，公司决定将该项目达到预定可使用状态的日期调整为2025年9月。 壹石通表示，本次部分募投项目延期仅涉及项目进度的变化，未改变募投项目的投资内容、投资总额、实施主体，不会对募投项目的实施造 成实质性影响。本次延期不存在改变或变相改变募集资金投向和其他损害股东利益的情形，不会对公司的正常经营 ...

国泰海通证券股份有限公司 关于采纳科技股份有限公司 部分募投项目再次延期的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通证券"或"保荐机构"） 作为采纳科技股份有限公司（以下简称"采纳股份"或"公司"）首次公开发行 股票并在创业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上 市公司募集资金监管规则》 《深圳证券交易所创业板股票上市规则》 《深圳证券交 ，公司获准向社会公开发行人民币 普通股（A股）股票2,350.88万股，每股面值人民币1.00元，发行价格为人民币50.31 元/股，募集资金总额为人民币1,182,727,728.00元，扣除各项发行费用人民币 超募资金总额为人民币693,369,702.40元。 公司与保荐机构、存放募集资金的银行签署了《募集资金专户存储三方监管 协议》，共同监管募集资金的使用。中汇会计师事务所（特殊普通合伙）对公司 首次公开发行股票募集资金到位情况进行了审验，并出具了"中汇会验 20220084号"的验资报告。 二、募集资金使用情况 根据公司《首次公开发行股票并在创业板上市招股说明书》披露，公司本次 公开发行股票募集资金投资项目及募集资金使用计划及截至2 ...

Core Viewpoint - The company has decided to terminate part of its fundraising projects and delay others, based on a careful assessment of the current market conditions and project progress, ensuring that these decisions align with the long-term interests of the company and its shareholders [1][10]. Fundraising Overview - The company raised a net amount of RMB 1,002,572,682.71 through its initial public offering, verified by an accounting firm [1]. - The company has established a management system for the use of raised funds, ensuring that funds are stored in dedicated accounts and used strictly for their intended purposes [2]. Termination of Fundraising Projects - The project "Zihang Medical Device Component Intelligent Manufacturing and Expansion Project" will be terminated, with the total investment amount reduced from RMB 282.84 million to RMB 143.47 million, and the fundraising investment amount decreased from RMB 282.84 million to RMB 135.77 million [3]. - The termination is influenced by changes in market demand and increased competition, leading to a reassessment of the project's viability [6][7]. Reasons for Project Termination - The implementation of centralized procurement policies has created volatility in market demand, affecting the sales cycle and capacity planning for the project [6]. - The existing production capacity is deemed sufficient to meet current demand, and further investment could lead to idle capacity risks [7]. Impact of Project Termination - The termination is expected to enhance the efficiency of fundraising usage and will not adversely affect the company's normal operations or shareholder interests [8]. - The remaining funds from the terminated project will be retained in dedicated accounts for future investment opportunities [8]. Delay of Fundraising Projects - The "Weike Medical Minimally Invasive Surgical New Product Project" will be delayed, with the expected completion date pushed from June 30, 2025, to December 31, 2027 [9]. - The delay is attributed to changes in market conditions and the need for further product development to meet diverse customer needs [9]. Reasons for Project Delay - The company is adapting to market changes and enhancing product features through increased R&D investment, which has necessitated a phased approach to project implementation [9]. - The execution of procurement policies has affected the expected market release timeline for the company's products [9]. Impact of Project Delay - The delay is a strategic decision that does not involve changes to the project’s implementation structure or total investment, ensuring that it aligns with the company's long-term development goals [9][10].